Dan Leonard is president & CEO of the National Pharmaceutical Council, which sponsors and participates in research on the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation. Leonard outlines the activities of the Council – which celebrated its 65th anniversary in 2018 – his priorities for 2020, and addresses the changes needed to transform US healthcare into a value-based system that will improve patient outcomes in the long-term.
We’re proud of our efforts to spark a broader, national dialogue on healthcare spending issues. The focus is on digging deeper to understand what is driving health spending and finding solutions, without finger-pointing at one healthcare sector over another
